EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 202 filers reported holding EDITAS MEDICINE INC in Q1 2019. The put-call ratio across all filers is 2.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,733,000 | +7.9% | 275,368 | +0.4% | 0.01% | -11.1% |
| Q4 2018 | $6,241,000 | -64.3% | 274,333 | -50.0% | 0.01% | -18.2% |
| Q3 2018 | $17,458,000 | +80.4% | 548,666 | +103.1% | 0.01% | -8.3% |
| Q2 2018 | $9,679,000 | +42.0% | 270,149 | +31.4% | 0.01% | +33.3% |
| Q1 2018 | $6,815,000 | +258.3% | 205,594 | +232.2% | 0.01% | +350.0% |
| Q4 2017 | $1,902,000 | +28.0% | 61,883 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,486,000 | +44.3% | 61,883 | +0.8% | 0.00% | +100.0% |
| Q2 2017 | $1,030,000 | +213.1% | 61,369 | +316.7% | 0.00% | – |
| Q1 2017 | $329,000 | +84.8% | 14,727 | +34.5% | 0.00% | – |
| Q4 2016 | $178,000 | +20.3% | 10,948 | 0.0% | 0.00% | – |
| Q3 2016 | $148,000 | -44.6% | 10,948 | 0.0% | 0.00% | – |
| Q2 2016 | $267,000 | +17.6% | 10,948 | +66.8% | 0.00% | – |
| Q1 2016 | $227,000 | – | 6,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |